APA (7th ed.) Citation

Schnittger, S., Bacher, U., Kern, W., Haferlach, T., & Haferlach, C. (2007). JAK2V617F as progression marker in CMPD and as cooperative mutation in AML with trisomy 8 and t(8;21): A comparative study on 1103 CMPD and 269 AML cases. Leukemia (08876924), 21(8), 1843. https://doi.org/10.1038/sj.leu.2404707

Chicago Style (17th ed.) Citation

Schnittger, S., U. Bacher, W. Kern, T. Haferlach, and C. Haferlach. "JAK2V617F as Progression Marker in CMPD and as Cooperative Mutation in AML with Trisomy 8 and T(8;21): A Comparative Study on 1103 CMPD and 269 AML Cases." Leukemia (08876924) 21, no. 8 (2007): 1843. https://doi.org/10.1038/sj.leu.2404707.

MLA (9th ed.) Citation

Schnittger, S., et al. "JAK2V617F as Progression Marker in CMPD and as Cooperative Mutation in AML with Trisomy 8 and T(8;21): A Comparative Study on 1103 CMPD and 269 AML Cases." Leukemia (08876924), vol. 21, no. 8, 2007, p. 1843, https://doi.org/10.1038/sj.leu.2404707.